
Zim Laboratories Ltd is Rated Strong Sell
2026-04-25 10:10:14Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 August 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis below presents the company’s current position as of 25 April 2026, incorporating the latest financial metrics, returns, and market data to provide investors with an up-to-date perspective.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-04-14 10:10:14Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-04-03 10:10:14Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd Falls to 52-Week Low of Rs 59.72 as Sell-Off Deepens
2026-03-30 15:16:50A sharp decline in Zim Laboratories Ltd saw the stock hit a fresh 52-week low of Rs 59.72 on 30 Mar 2026, marking a significant 53% drop from its 52-week high of Rs 126.95. This fall comes amid a broader market downturn, but the stock’s underperformance has been notably more severe, raising questions about the underlying factors driving this sell-off.
Read full news article
Zim Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens
2026-03-23 14:37:37A sharp decline of 8.16% today dragged Zim Laboratories Ltd to a fresh 52-week low of Rs 63, extending its downward trajectory amid broader market weakness and company-specific concerns.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-23 10:10:16Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-22 10:10:13Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd Stock Falls to 52-Week Low of Rs.63.48
2026-03-16 13:27:58Zim Laboratories Ltd has reached a new 52-week low of Rs.63.48 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance concerns.
Read full news article
Zim Laboratories Ltd Stock Hits 52-Week Low at Rs.64 Amidst Continued Downtrend
2026-03-13 10:05:26Zim Laboratories Ltd has touched a new 52-week low of Rs.64 today, marking a significant decline in its stock price amid a broader bearish trend in the Pharmaceuticals & Biotechnology sector. The stock has been under pressure for the past two days, falling by 4.42% during this period, and continues to trade below all key moving averages.
Read full news articleAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
18-Apr-2026 | Source : BSEPursuant to Regulation 30 of SEBI (LODR) Regulations please find enclosed the disclosure w.r.t allotment of 48726 equity shares pursuant to exercise of options under ZIM Laboratories Employee Stock Option Scheme 2023
Announcement under Regulation 30 (LODR)-Updates on Acquisition
09-Apr-2026 | Source : BSEIn continuation of the disclosures dt. 13.05.2024 and 02.07.2024 we wish to inform you that out of the approved investment amount of upto Rs. 2 crores the Company has invested Rs. 8945100 in the equity share capital of ZIMTAS PTY LTD subsidiary of the Company.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Apr-2026 | Source : BSECertificate under Reg.74 (5) of SEBI (DP) Regulations 2018 is enclosed herewith for the quarter ended 31st March 2026.
Corporate Actions
No Upcoming Board Meetings
Zim Laboratories Ltd has declared 5% dividend, ex-date: 19 Sep 19
No Splits history available
Zim Laboratories Ltd has announced 2:1 bonus issue, ex-date: 22 Dec 22
No Rights history available






